Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse

REFERENCES

• Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–366.
   PubMed Web of Science ®Google Scholar
• Lopez EJ, Jones DL, Villar-Loubet OM, Arheart KL, Weiss SM. Violence, coping, and consistent medication adherence in HIV-positive couples. AIDS Educ Prev. 2010;22(1):61.
   PubMed Web of Science ®Google Scholar
• Gardner EM, Sharma S, Peng G, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008;22(1):75–82.
   PubMed Web of Science ®Google Scholar
• García dOP, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. JAIDS. 2002;30(1):105–110.
   Google Scholar
• Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111–1117.
   PubMed Web of Science ®Google Scholar
• Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV: infected drug users. J Gen Intern Med. 2002;17(5):377–381.
   PubMed Web of Science ®Google Scholar
• Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV: infected drug users. J Gen Intern Med. 2003;18(4):248–257.
   PubMed Web of Science ®Google Scholar
• Delgado J, Heath KV, Yip B, et al. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antivir Ther. 2003;8(5):471–478.
   PubMed Web of Science ®Google Scholar
• Tapp C, Milloy M, Kerr T, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11(1):86.
   PubMed Web of Science ®Google Scholar
• Malow R, Devieux JG, Stein JA, et al. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav. 2013;17(4):1221–1230.
   PubMed Web of Science ®Google Scholar
• Prevention CfDCa. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV: United States, 2011. MMWR. 2014;63:1–6.
   Google Scholar
• Meade CS, Hansen NB, Kochman A, Sikkema KJ. Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse. AIDS Patient Care STDS. 2009;23(4):259–266.
   PubMed Web of Science ®Google Scholar
• Liu H, Longshore D, Williams JK, et al. Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse. AIDS Behav. 2006;10(3):279–286.
   PubMed Web of Science ®Google Scholar
• Arriola KR, Louden T, Doldren MA, Fortenberry RM. A meta-analysis of the relationship of child sexual abuse to HIV risk behavior among women. Child Abuse Negl. 2005;29(6):725–746.
   PubMed Web of Science ®Google Scholar
• Briere J, Runtz M. Symptomatology associated with childhood sexual victimization in a nonclinical adult sample. Child Abuse Negl. 1988;12(1):51–59.
   PubMed Web of Science ®Google Scholar
• Finkelhor D. Long term effects of childhood sexual abuse. New Theory and Research. New York, NY: Free Press; 1984.
   Google Scholar
• Finkelhor D, Browne A. The traumatic impact of child sexual abuse: a conceptualization. Am J Orthopsychiatr. 1985;55(4):530.
   PubMed Web of Science ®Google Scholar
• Markowitz SM, O'Cleirigh C, Hendriksen ES, Bullis JR, Stein M, Safren SA. Childhood sexual abuse and health risk behaviors in patients with HIV and a history of injection drug use. AIDS Behav. 2011;15(7):1554–1560.
   PubMed Web of Science ®Google Scholar
• Mugavero MJ, Pence BW, Whetten K, et al. Childhood abuse and initial presentation for HIV care: an opportunity for early intervention. AIDS Care. 2007;19(9):1083–1087.
   PubMed Web of Science ®Google Scholar
• Cohen M, Deamant C, Barkan S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health. 2000;90(4):560–565.
   PubMed Web of Science ®Google Scholar
• Henny KD, Kidder DP, Stall R, Wolitski RJ. Physical and sexual abuse among homeless and unstably housed adults living with HIV: prevalence and associated risks. AIDS Behav. 2007;11(6):842–853.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Sikkema KJ, DiFonzo K, Luke W, Austin J. Emotional adjustment in survivors of sexual assault living with HIV/AIDS. J Trauma Stress. 2002;15(4):289–296.
   PubMed Web of Science ®Google Scholar
• Machtinger E, Wilson T, Haberer J, Weiss D. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091–2100.
   PubMed Web of Science ®Google Scholar
• Wyatt GE, Carmona JV, Loeb TB, Williams JK. HIV-positive black women with histories of childhood sexual abuse: patterns of substance use and barriers to health care. J Health Care Poor Underserved. 2005;16(4 Suppl B):9–23.
   PubMed Web of Science ®Google Scholar
• Liebschutz JM, Geier JL, Horton NJ, Chuang CH, Samet JH. Physical and sexual violence and health care utilization in HIV-infected persons with alcohol problems. AIDS Care. 2005;17(5):566–578.
   PubMed Web of Science ®Google Scholar
• Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS. 2006;20(6):418–428.
   PubMed Web of Science ®Google Scholar
• Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261–269.
   PubMed Web of Science ®Google Scholar
• Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. JAIDS. 2011;58(2):181–187.
   Google Scholar
• Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS. 2003;17(4):179–186.
   PubMed Web of Science ®Google Scholar
• Himelhoch S, Moore RD, Treisman G, Gebo KA. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? JAIDS. 2004;37(4):1457–1463.
   Google Scholar
• Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol. 2004;23(4):363–370.
   PubMed Web of Science ®Google Scholar
• Schönnesson LN, Williams ML, Ross MW, Bratt G, Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS Behav. 2007;11(2):175–183.
   PubMed Web of Science ®Google Scholar
• Safren SA, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1–10.
   PubMed Web of Science ®Google Scholar
• Cook JA, Grey D, Burke-Miller J, et al. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care. 2006;18(2):93–100.
   PubMed Web of Science ®Google Scholar
• Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. JAIDS. 2005;38(4):432–438.
   Google Scholar
• Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223–1229.
   PubMed Web of Science ®Google Scholar
• Ogedegbe GO, Boutin-Foster C, Wells MT, et al. A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med. 2012;172(4):322–326.
   PubMed Web of Science ®Google Scholar
• Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med. 2003;65(4):620–626.
   PubMed Web of Science ®Google Scholar
• Meade CS, Drabkin AS, Hansen NB, Wilson PA, Kochman A, Sikkema KJ. Reductions in alcohol and cocaine use following a group coping intervention for HIV: positive adults with childhood sexual abuse histories. Addiction. 2010;105(11):1942–1951.
   PubMed Web of Science ®Google Scholar
• Sikkema KJ, Ranby KW, Meade CS, Hansen NB, Wilson PA, Kochman A. Reductions in traumatic stress following a coping intervention were mediated by decreases in avoidant coping for people living with HIV/AIDS and childhood sexual abuse. J. Consult Clin Psychol. 2013;81(2):274–283.
   PubMed Web of Science ®Google Scholar
• Sikkema KJ, Wilson PA, Hansen NB, et al. Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse. JAIDS. 2008;47(4):506–513.
   Google Scholar
• Kaplan ML, Erensaft M, Sanderson WC, Wetzler S, Foote B, Asnis GM. Dissociative symptomatology and aggressive behavior. Compr Psychiatr. 1998;39(5):271–276.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatr. 1961;4(6):561–571.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation; 1990.
   Google Scholar
• Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
   Web of Science ®Google Scholar
• Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–580.
   PubMed Web of Science ®Google Scholar
• Molassiotis A, Nahas-Lopez V, Chung WR, Lam SC, Li CP, Lau TJ. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS. 2002;13(5):301–310.
   PubMed Web of Science ®Google Scholar
• Wolf TM, Balson PM, Morse EV, et al. Relationship of coping style to affective state and perceived social support in asymptomatic and symptomatic HIV-infected persons: Implications for clinical management. J Clin Psychol. 1991;52:171–173.
   Web of Science ®Google Scholar
• Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS. 2014;28(3):136–143.
   PubMed Web of Science ®Google Scholar
• Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS. 2005;19(18):2057–2067.
   PubMed Web of Science ®Google Scholar
• Murphy DA, Wilson C, Durako S, Muenz L, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27–40.
   PubMed Web of Science ®Google Scholar
• Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175–1183.
   PubMed Web of Science ®Google Scholar
• Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15(5):311–320.
   PubMed Web of Science ®Google Scholar
• HIV Surveillance Report, 2011. Washington, DC: Centers for Disease Control and Prevention; February 2013.
   Google Scholar
• Anastos K, Schneider MF, Gange SJ, et al. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. JAIDS. 2005;39(5):537–544.
   Google Scholar
• Thames AD, Moizel J, Panos SE, et al. Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDS. 2012;26(10):621–630.
   PubMed Web of Science ®Google Scholar
• Aaron E, Criniti S, Bonacquisti A, Geller PA. Providing sensitive care for adult HIV-infected women with a history of childhood sexual abuse. J Assoc Nurses AIDS Care. 2013;24(4):355–367.
   PubMed Web of Science ®Google Scholar
• Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–977.
   PubMed Web of Science ®Google Scholar
• Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004;94(7):1147–1151.
   PubMed Web of Science ®Google Scholar
• McNutt L-A, van Ryn M, Clark C, Fraiser I. Partner violence and medical encounters: African-American women's perspectives. Am J Prev Med. 2000;19(4):264–269.
   PubMed Web of Science ®Google Scholar